Delivery Order SPE2DB22D1103-SPE2DB24FTKT4
Award Date 5/15/24
Potential Completion Date 5/16/24
Potential Value $1.7K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of the medication ENGERIX-B 20 MCG/ML VIALML. The $2,056.29 firm fixed price delivery order was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract has an ultimate completion date of February 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. The $1,677.10 fixed-price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of May 28, 2024. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ENGERIX-B PEDI 10 MCG/0.5 SYRN 0.5ML, a pharmaceutical product. The $14,626.98 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,712,501 units of the ENGERIX-B 20 MCG/ML SYRNML pharmaceutical product. The $50,413.81 firm fixed-price delivery order was awarded on May 24, 2024 by the Defense Logistics Agency (DLA), a defense agency, with a completion date of May 28, 2024. The contract does not have a set-aside designation. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a division of Amerisourcebergen Corporation, is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the U.S. government. The contract has a ceiling value of $1,693.70 and an ultimate completion date of May 6, 2024. The contract is a Delivery Order placed by the Defense Logistics Agency (DLA) Troop Support Medical, a subdivision of the Department of Defense (DoD). Amerisourcebergen holds a larger Indefinite...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,655.75 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a completion date of June 11, 2024. Amerisourcebergen, as a major pharmaceutical distribution company, holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support Medical through December 31,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,689.62 firm fixed-price delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has an ultimate completion date of September 16, 2024 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide the ENGERIX-B 20 MCG/ML SYRNML vaccine. The $1,051.94 firm fixed price delivery order has a completion date of July 15, 2024. Amerisourcebergen, through its Corporate Office division, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 2025, which serves as the...
- This federal contract award is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,751.90 firm fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 5, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and supplier. The $1,365.38 Firm Fixed Price Delivery Order is for the provision of ENGERIX-B 20 MCG/ML SYRNML, a vaccine product. The contract has an ultimate completion date of April 24, 2024 and is not set aside for any specific business categories. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...